Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
44.95
-0.24 (-0.52%)
Dec 23, 2024, 4:00 PM EST - Market closed
Soleno Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 23, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 1,938 | 1,228 | 16 | 33 | 154 | 131 | |
| Market Cap Growth | 335.62% | 7498.61% | -50.63% | -78.71% | 17.03% | 142.15% | |
| Enterprise Value | 1,656 | 1,176 | -3 | 5 | 98 | 120 | |
| Last Close Price | 44.95 | 40.25 | 1.98 | 6.15 | 28.95 | 44.10 | |
| PB Ratio | 6.97 | 7.79 | 1.56 | 1.84 | 3.37 | 8.78 | |
| P/TBV Ratio | 7.62 | 8.25 | - | 6.35 | 4.96 | - | |
| Debt / Equity Ratio | 0.01 | 0.00 | 0.01 | 0.03 | 0.00 | 0.03 | |
| Quick Ratio | 17.16 | 14.75 | 2.00 | 2.66 | 5.71 | 4.18 | |
| Current Ratio | 17.26 | 14.89 | 2.14 | 2.80 | 5.83 | 4.26 | |
| Return on Equity (ROE) | -91.11% | -46.45% | -171.05% | -97.60% | -81.46% | -135.69% | |
| Return on Assets (ROA) | -48.05% | -23.33% | -50.58% | -40.11% | -38.72% | -35.66% | |
| Return on Capital (ROIC) | -59.39% | -28.70% | -109.16% | -63.06% | -65.35% | -63.27% | |
| Earnings Yield | -6.77% | -3.18% | -148.97% | -94.47% | -16.03% | -23.44% | |
| FCF Yield | -2.66% | -2.03% | -128.71% | -84.94% | -16.42% | -13.25% | |
| Buyback Yield / Dilution | -271.22% | -96.40% | -57.90% | -27.39% | -83.41% | -62.77% | |
| Total Shareholder Return | -271.22% | -96.40% | -57.90% | -27.39% | -83.41% | -62.77% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.